Peritoneal dialysis-related peritonitis caused by Mycobacterium iranicum: A case report and literature review
Abstract
Mycobacterium iranicum is an emerging scotochromogenic, rapidly growing mycobacterium (RGM) known to cause infections in multiple organ systems. However, because only a limited number of M. iranicum infections have been reported, optimal treatments have not been established. Here, we describe the case of a man in his 80s who developed peritoneal dialysis (PD)-related peritonitis caused by M. iranicum. Dialysate cultures yielded RGM, which was subsequently identified as M. iranicum using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. After PD catheter removal, a multidrug regimen comprising amikacin, meropenem, and azithromycin was initiated. To assess inducible macrolide resistance, antimicrobial susceptibility testing with 14 days of incubation was performed, confirming macrolide susceptibility. The patient transitioned to oral azithromycin and levofloxacin and completed a 3-month course without recurrence. To our knowledge, this is the first reported case of M. iranicum PD-related peritonitis treated with an azithromycin-containing regimen. The literature review suggests that, although M. iranicum may show in vitro susceptibility to several agents used for RGM infections, the detection of the plasmid-borne erm(55) gene in M. iranicum warrants caution when interpreting macrolide susceptibility results. Macrolide susceptibility was evaluated through 14 days in this case; however, resistance genes were not assessed, and the contribution of…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.